3[1]Zoltan Pragai ,et al. Charaterization of the extened-spctrum β -lactamases and determination of the antibiotic susceptibilities of Klebsiella pneumoniae isolates in Hungary[J]. J Antimicrob Chemother, 1998, 42:401～403.
4[4]Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β -Lactamases and its correlation with molecular structure[J]. Antimicrob Agents Chemother,1995,39(6): 1211～1233.
6Denny BJ, Lambert PA, West PW. The flavonoid galangin inhibits the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia. FEMS Microbiol Lett, 2002,208 ( 1 ) : 21-24.
7Valdezate S, Vindel A, Loza E,et al. Topoisomerase Ⅱ and Ⅳ quinolong resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility. Antimicrob Agents Chemother, 2002,46 ( 3 ) : 665.
8Ribera A, Domenech SA, Ruiz J, et al. Mutation in gyrA and parC QRDRs are not relavant for quinolone resistance in epidemiological unrelated Stenotrophomonas maltophilia clinical isolates. Microb Drug Resist,2002,8(4) :245-251.
9Zhang L,Li XZ, Poole,Keith. Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa,Stenotrophomonas maltophilia and Burkholderia cepacia. Journal of Antimicrobial Chemotherapy,2001,48(4) :549-552.
10Ribera A,Jurado A, Ruiz J,et al. In vitro activity of clinafloxaein in comparison with other quinolones against Stenotrophomonas maltophilia clinical isolates in the presence and absence of reserpine. Diagn Microbiol Infect Dis,2002,42(2) :123-128.
